Back to search
FDAFDA · Food and drugs·Recall number D-0728-2026

Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01

Published July 29, 2026 · Recall initiated: July 16, 2026

Summary

FDA records drug Class II recall D-0728-2026, published July 29, 2026 and initiated July 16, 2026. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 93,250 vials; Lot: Lot #: 6130235, Exp. Date 02/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Hair was found in products

What to do

Voluntary: Firm initiated · Letter

Get an email if XYLOCAINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
XYLOCAINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide within in the USA
UPC
0363323484576
Lot
Lot #: 6130235, Exp. Date 02/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01 recalled?

Yes. FDA published recall D-0728-2026 on July 29, 2026. Reported hazard: Presence of Particulate Matter: Hair was found in products

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: XYLOCAINE. UPC: 0363323484576.